1. Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals 
C. Torti, L. Bono, F. Gargiulo, M.C. Uccelli, E. Quiros-Roldan, A. Patroni, G. Paraninfo, V. Tirelli, N. Manca, M.A. De Francesco, F. Perandin, G. Carosi 
Clinical Microbiology and Infection 
Volume 10, Issue 9, Pages (September 2004)
DOI: /j x
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

2. FIG. 1
Prevalence of mutations (both canonical and atypical) at positions indicated by the International AIDS Society (IAS) in HIV strains from the study patients. N(t)RTI, nucleoside (nucleotide) reverse transcriptase inhibitor; NNRTI, non-nucleoside reverse transcriptase inhibitor; PI, protease inhibitor.
Clinical Microbiology and Infection  , DOI: ( /j x)
Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions